ArticleProceedings of the National Academy of Sciences of the United States of America2025
Strategic planning of prevention and surveillance for emerging diseases and invasive species.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A cetacean-specific CNE suppresses osteogenesis to drive appendicular modification in secondary aquatic adaptation.iScience · 2026Article
- Choosing structure over complexity: POMDPs for emerging diseases and invasive species.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
Corrections and comments
- Commented on by
Authors and funding
11 authors.
Funding
Abstract
Emerging infectious diseases and biological invasions pose increasing threats to public and ecosystems health. Proactive measures-such as prevention and surveillance taken before initial detection of the pathogen or species-are essential to ensure minimal spread prior to first detection. We developed an optimization model to determine where, when, and how much effort should be allocated to prevention versus surveillance. The model accounts for imperfect detection, system dynamics, spatial heterogeneity in risk and costs and is scalable to large landscapes. We found that the most cost-effective strategy is to maintain the prevention and surveillance efforts at stable equilibrium for the majority of the time, with deviations occurring only initially to steer the system toward the equilibrium. The equilibrium effort is jointly determined by the introduction risk, management costs, and total budget. Application of this model to chronic wasting disease in New York State suggests that the optimal strategy could reduce the cumulative disease cases before initial detection by an average of 22% compared to current practice. The optimal surveillance strategy could detect the disease on average over 8 mo earlier than the current strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.